Children's Hospital of Philadelphia leads or participates in hundreds of clinical trials. Use this database to learn the purpose of these trials, find out who can participate and more.
151 - 152 of 152
This is a study that investigates whether an IV medication (teplizumab) will slow or halt the progression of type 1 diabetes in children and adolescents (ages 8 - 17 years). Eligible participants will be randomly assigned to receive either the study medication or an inactive substance called a placebo. All participants will receive two courses of IV infusions, six months apart from each other. During each treatment course, participants will come to CHOP for daily teplizumab or placebo infusions for 12 days. Study participation, including treatments and follow-up visits, lasts for 1.5 years.
The goal of this research study is to develop an online questionnaire about what youth with Autism Spectrum Disorder (ASD) eat and how it impacts their daily lives. Youth (7-16 years) and their parent will complete a questionnaire about food and eating habits online. Parents will complete an additional child background and medical history questionnaire online. Participants will be paid for their time with an Amazon online gift card.